Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the end of the debate

被引：24
|
作者：
Poggio, F. [1 ]
Tagliamento, M. [2 ,3 ]
Ceppi, M. [4 ]
Bruzzone, M. [4 ]
Conte, B. [1 ,2 ]
Fregatti, P. [5 ,6 ]
Punie, K. [7 ,8 ]
de Azambuja, E. [9 ]
Del Mastro, L. [2 ,10 ]
Lambertini, M. [2 ,11 ]
机构：
[1] IRCCS Osped Policlin San Martino, Oncol Med 2, Genoa, Italy
[2] Univ Genoa, Sch Med, Dept Internal Med & Med Specialties DiMI, Genoa, Italy
[3] Gustave Roussy, Dept Canc Med, Villejuif, France
[4] IRCCS Osped Policlin San Martino, Clin Epidemiol Unit, Genoa, Italy
[5] IRCCS Osped Policlin San Martino, Dept Surg, UOC Clin Chirurg Senol, Genoa, Italy
[6] Univ Genoa, Sch Med, Dept Integrated Diagnost Surg Sci, Genoa, Italy
[7] Univ Hosp Leuven, Leuven Canc Inst, Dept Gen Med Oncol, Leuven, Belgium
[8] Univ Hosp Leuven, Leuven Canc Inst, Multidisciplinary Breast Ctr, Leuven, Belgium
[9] Univ Libre Bruxelles ULB, Inst Jules Bordet, Brussels, Belgium
[10] IRCCS Osped Policlin San Martino, Breast Unit, Genoa, Italy
[11] IRCCS Osped Policlin San Martino, Dept Med Oncol, UOC Clin Oncol Med, Genoa, Italy
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 03期
关键词：
D O I：
10.1016/j.annonc.2021.11.016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：347 / 349
页数：3
相关论文
共 50 条
  • [41] Efficacy of platinum-based neoadjuvant chemotherapy in early triple-negative breast cancer according to germline BRCA mutation
    Bae, S. J.
    Jang, J. S.
    Kook, Y.
    Baek, S. H.
    Kim, J. H.
    Kim, M. J.
    Lee, S. E.
    Moon, S.
    Kim, J. H.
    Ahn, S. G.
    Jeong, J.
    BREAST, 2023, 68 : S59 - S60
  • [42] Neoadjuvant treatments for triple-negative breast cancer (TNBC)
    von Minckwitz, G.
    Martin, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 35 - 39
  • [43] Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
    Silver, Daniel P.
    Richardson, Andrea L.
    Eklund, Aron C.
    Wang, Zhigang C.
    Szallasi, Zoltan
    Li, Qiyuan
    Juul, Nicolai
    Leong, Chee-Onn
    Calogrias, Diana
    Buraimoh, Ayodele
    Fatima, Aquila
    Gelman, Rebecca S.
    Ryan, Paula D.
    Tung, Nadine M.
    De Nicolo, Arcangela
    Ganesan, Shridar
    Miron, Alexander
    Colin, Christian
    Sgroi, Dennis C.
    Ellisen, Leif W.
    Winer, Eric P.
    Garber, Judy E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) : 1145 - 1153
  • [44] Neoadjuvant platin and bevacizumab in triple-negative breast cancer
    Kern, P.
    Otterbach, F.
    Kolberg, H. C.
    Pott, D.
    Kalisch, A.
    Kimmig, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [45] Assessing the benefits and toxicities of platinum containing neoadjuvant chemotherapy in triple negative breast cancer
    Jarral, K.
    Kancherla, K.
    Arif, Z.
    Sharma, S.
    Kaushik, M.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S57 - S57
  • [46] Dynamics of ctDNA changes during neoadjuvant chemotherapy in triple-negative breast cancer patients
    Cavallone, Luca
    Adriana, Aguilar-Mahecha
    Aldamry, Mohammed
    Lafleur, Josianne
    Cathy, Lan
    Alirezaie, Najmeh
    Bareke, Eric
    Majewski, Jacek
    Ferrario, Cristiano
    Mihalciou, Catalin
    Roy, Josee-Anne
    Markus, Elisabeth
    Robidoux, Andre
    Pelmus, Manuela
    Aleynikova, Olga
    Discepola, Federico
    Basik, Mark
    CANCER RESEARCH, 2018, 78 (04)
  • [47] A gene signature predicts response to neoadjuvant chemotherapy in triple-negative breast cancer patients
    Zheng, Tianzhi
    Pang, Zhiyuan
    Zhao, Zhao
    BIOSCIENCE REPORTS, 2019, 39
  • [48] Impact of Neoadjuvant Chemotherapy on Extent of Axillary Surgery in Patients With Triple-Negative Breast Cancer
    Connor, Carol S.
    Kimler, Bruce
    Mammen, Joshua M.
    McGinness, Marilee K.
    Wagner, Jamie L.
    Alsop, Samantha M.
    Ward, Claire
    Fabian, Carol
    Khan, Qamar
    Sharma, Priyanka
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : 38 - 39
  • [49] Prognostic Factors for Triple-Negative Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy
    Li, Zhijun
    Han, Yiqun
    Wang, Jiayu
    Xu, Binghe
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (02):
  • [50] Evaluation of neoadjuvant chemotherapy for clinical T1 triple-negative breast cancer
    Hao, Qian
    Dai, Luyao
    Chang, Lidan
    Song, Dingli
    Liu, Dandan
    Ma, Xiaobin
    Wu, Hao
    Kang, Huafeng
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345